A DATA 2000 Waiver, also known as an X-waiver, is a federal authorization that lets qualified healthcare providers prescribe buprenorphine for opioid use disorder (OUD) in regular office settings—not just in specialized opioid treatment programs.
What does DATA 2000 allow?
DATA 2000 lets qualified doctors, nurse practitioners, and physician assistants prescribe buprenorphine for opioid use disorder in their offices instead of only in opioid treatment programs.
This law opened the door to medication-assisted treatment (MAT) by letting providers use certain FDA-approved controlled substances for OUD outside of traditional treatment centers. To qualify, providers must complete specific training and licensing. Come 2026, the waiver system keeps changing to make evidence-based OUD treatment more accessible nationwide.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), DATA 2000 was designed to weave addiction treatment into regular healthcare.
What is a DATA-waived provider?
A DATA-waived provider is a healthcare professional certified by SAMHSA and the DEA to prescribe buprenorphine for opioid use disorder in office-based settings.
These providers must finish required training and get a special DEA registration number that starts with an “X.” As of 2026, eligible providers include doctors, nurse practitioners, physician assistants, certified nurse midwives, and clinical nurse specialists—though state laws may limit who can actually prescribe. Once certified, they have 30 days to tell SAMHSA and the DEA if their main practice address changes.
How long does it take to get a Suboxone waiver?
SAMHSA usually reviews waiver applications within 45 days and makes a decision by then.
If approved, you’ll get an email confirmation and a unique prescribing ID number to use on all buprenorphine prescriptions. The timeline can shift slightly depending on how many applications are in the queue and how complete your submission is. Don’t forget the training—doctors need 8 hours, while other eligible providers need 24 hours before applying. Once approved, new waivers let you prescribe for up to 30 patients in the first year.
How do I get a buprenorphine waiver?
To get a buprenorphine waiver, finish the required training, apply through SAMHSA, and get a DEA registration with an “X” identifier.
Doctors need 8 hours of training, while nurse practitioners, physician assistants, and other mid-level providers need 24 hours. After training, submit your application through SAMHSA’s online portal and pay the DEA registration fee to receive your “X-waiver.” Once approved, you’re cleared to prescribe buprenorphine for OUD in office settings. Some states tack on extra rules, so double-check local laws.
For step-by-step help, check out the SAMHSA MAT website.
Do you need a waiver to prescribe buprenorphine for pain?
No DATA 2000 waiver is needed if you’re prescribing buprenorphine only for pain.
If you’re using it for chronic pain according to FDA-approved labeling, no “X-waiver” is required. But if you’re treating opioid use disorder, you do need one. Providers should clearly document the reason in the medical record to avoid mix-ups. As of 2026, pain-focused buprenorphine products like Butrans don’t need a waiver, while OUD treatments like Suboxone do.
What did the Drug Addiction Treatment Act of 2000 do?
The Drug Addiction Treatment Act of 2000 (DATA 2000) created the legal foundation for office-based treatment of opioid use disorder using FDA-approved meds like buprenorphine.
Passed as part of the Children’s Health Act of 2000, DATA 2000 let qualified doctors prescribe and dispense controlled substances for OUD outside traditional opioid treatment programs. It set up the MAT waiver system and dramatically expanded access to evidence-based addiction care. As of 2026, it still stands as the backbone of federal OUD treatment policy in the U.S.
What does “DATA Waiver” mean?
A DATA Waiver, often called an X-waiver, is a federal certification that lets qualified providers prescribe buprenorphine for opioid use disorder in outpatient settings.
This waiver is required for providers who want to treat OUD with buprenorphine outside licensed opioid treatment programs. It ensures providers meet SAMHSA and DEA training and regulatory standards. Once granted, providers get a unique DEA registration number with an “X” prefix, which lets them prescribe buprenorphine for addiction treatment.
Do you need a waiver to prescribe naltrexone?
No waiver is required to prescribe naltrexone for opioid or alcohol use disorder.
Naltrexone isn’t a controlled substance, so any licensed provider with prescriptive authority can prescribe it. It works by blocking opioid receptors and helps prevent relapse in recovery. Unlike buprenorphine, naltrexone doesn’t need a DATA 2000 waiver or DEA “X” registration. Still, follow standard prescribing guidelines and watch for contraindications.
How do I get MAT certified?
To get MAT certified, finish a SAMHSA-recognized buprenorphine training program, pass required exams, and complete DEA registration steps to get your X-waiver.
Most providers train through PCSS-MAT, ASAM, or other SAMHSA-approved programs. The process includes coursework, a post-test, and evaluation submission. After finishing, you’ll get a certificate and instructions for applying for the waiver through SAMHSA. Once approved, you can prescribe buprenorphine for OUD within your authorized patient limit. Some states also require extra state-level certification.
Is Suboxone the same as buprenorphine?
No, Suboxone isn’t the same as buprenorphine—it’s a combo of buprenorphine and naloxone in a 4:1 ratio.
Buprenorphine is the active opioid partial agonist, while naloxone is an opioid blocker added to deter misuse. Subutex contains only buprenorphine and is used in specific cases. Both are Schedule III controlled substances. Suboxone is FDA-approved for OUD and is a mainstay in MAT programs.
Can a nurse practitioner prescribe Suboxone?
Yes, nurse practitioners (NPs) can prescribe Suboxone, but they must first complete 24 hours of MAT training and get a DATA 2000 waiver.
After training and waiver approval, NPs can prescribe buprenorphine for up to 30 patients in their first year. They can then apply to increase their limit to 100 or 275, depending on extra qualifications and state rules. Some states add their own requirements, so NPs should check with their state boards.
Can nurse practitioners prescribe buprenorphine for pain?
Yes, nurse practitioners (NPs) and physician assistants (PAs) can prescribe buprenorphine for pain without a DATA 2000 waiver—as long as it’s for pain, not OUD.
Pain-focused buprenorphine products like Butrans or Belbuca can be prescribed by NPs within their state scope of practice and DEA registration. But if the goal is treating OUD, a waiver is required. As of 2026, all states let NPs and PAs prescribe buprenorphine for pain without extra federal waiver hurdles.
Can any doctor prescribe buprenorphine?
Since late 2023, federal rules dropped the “X-waiver” requirement for doctors to prescribe buprenorphine for OUD, so most physicians can now prescribe without extra certification.
This change aimed to make buprenorphine treatment more widely available. Doctors still need a valid DEA registration, but they no longer have to do the 8-hour training or get a separate waiver. Their DEA number no longer needs the “X” identifier for OUD treatment in office settings. Some states, though, may keep their own extra rules.
What is buprenorphine used for?
Buprenorphine is mainly used to treat opioid use disorder by easing withdrawal symptoms and cravings.
It’s also used off-label for chronic pain in certain formulations. As a partial opioid agonist, it binds to opioid receptors with less intensity than full agonists like heroin or oxycodone. That helps stabilize patients while lowering misuse and overdose risk. FDA-approved buprenorphine products for OUD include Suboxone, Subutex, and generic buprenorphine/naloxone films.
Is buprenorphine a controlled substance?
Yes, buprenorphine is a Schedule III controlled substance under the Controlled Substances Act.
Schedule III drugs have a moderate to low risk of physical and psychological dependence. Buprenorphine’s classification reflects its lower abuse potential compared to full opioids like oxycodone or morphine, which are Schedule II. Even though it’s controlled, buprenorphine is widely used in MAT for OUD because of its safety and effectiveness when prescribed correctly.
